BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 849 | Download: 677
Publication Name World Journal of Cardiology
Manuscript ID 7177
Country Greece
Received
2013-11-07 13:53
Peer-Review Started
2013-11-08 19:27
To Make the First Decision
2013-11-19 13:03
Return for Revision
2013-11-20 16:13
Revised
2013-12-04 18:58
Second Decision
2014-01-14 18:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-14 20:03
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-02-07 19:16
Typeset the Manuscript
2014-02-23 16:15
Publish the Manuscript Online
2014-02-25 15:28
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Topic Highlights
Article Title Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives
Manuscript Source Invited Manuscript
All Author List Georgios K Efthimiadis, Efstathios D Pagourelias, Thomas Gossios and Thomas Zegkos
Funding Agency and Grant Number
Corresponding Author Georgios K Efthimiadis, MD, Cardiomyopathies Center, First Cardiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 1 Al Svolou str, 54622 Thessaloniki, Greece. efthymos@med.auth.gr
Key Words Hypertrophic cardiomyopathy; Preclinical diagnosis; Left ventricular outflow obstruction; Sudden cardiac death; Genetic analysis
Core Tip Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiomyopathic process with an autosomal dominant trait of inheritance. This review incorporates contemporary research findings and addresses major and controversial aspects of HCM, including preclinical diagnosis, genetic analysis, left ventricular outflow tract obstruction, sudden cardiac death, myocardial ischemia and atrial fibrillation. Rather than enumerating clinical studies and guidelines, challenging problems concerning the disease are critically appraised by this review, highlighting current speculations and recommending future directions.
Publish Date 2014-02-25 15:28
Citation Efthimiadis GK, Pagourelias ED, Gossios T, Zegkos T. Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives. World J Cardiol 2014; 6(2): 26-37 Available from: URL: http://www.wjgnet.com/1949-8462/full/v6/i2/26.htm DOI: http://dx.doi.org/10.4330/wjc.v6.i2.26
URL http://www.wjgnet.com/1949-8462/full/v6/i2/26.htm
DOI http://dx.doi.org/10.4330/wjc.v6.i2.26
Full Article (PDF) WJC-6-26.pdf
Full Article (Word) WJC-6-26.doc
Manuscript File 7177-Review.doc
Answering Reviewers 7177-Answering reviewers.pdf
Copyright License Agreement 7177-Copyright assignment.pdf
Peer-review Report 7177-Peer reviewer(s).pdf
Scientific Editor Work List 7177-Scientific editor work list.doc